Source: International Congress 2017 – Molecular pathways in lung development
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. El Agha (Giessen, Germany). Mesenchymal lineage formation in the lung during development and disease. 2092

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Diversity in mesenchymal lineages during early human lung development Source: International Congress 2018 – Molecular and cellular determinants of the developing lung Year: 2018 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Mesenchymal stem cell therapy for severe emphysema Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stem cell therapy for severe emphysema Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer Year: 2021 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Mesenchymal cells, immune cells and the lung stem cell niche Source: Eur Respir Monogr 2021; 91: 134-143 Year: 2021 3D models of human lung development and disease using pluripotent stem cells Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 YI04 - Recruitment of stem cell populations to the lung with disease Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Alveolar stem cells in lung development and regrowth Source: Eur Respir Monogr 2021; 91: 17-30 Year: 2021 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021